Updates in Small Interfering RNA for the Treatment of Dyslipidemias

PURPOSE OF REVIEW: Atherosclerotic cardiovascular disease (ASCVD) is still the leading cause of death worldwide. Despite excellent pharmacological approaches, clinical registries consistently show that many people with dyslipidemia do not achieve optimal management, and many of them are treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Carugo, S., Sirtori, C. R., Gelpi, G., Corsini, A., Tokgozoglu, L., Ruscica, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618314/
https://www.ncbi.nlm.nih.gov/pubmed/37792132
http://dx.doi.org/10.1007/s11883-023-01156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618314/
https://www.ncbi.nlm.nih.gov/pubmed/37792132
http://dx.doi.org/10.1007/s11883-023-01156-5

Ejemplares similares